J Clin Oncol 33 (1): 13-21, 2015.[PUBMED Abstract] Schmid P, Cortes J, Pusztai L, et al.: Pembrolizumab for Early Triple-Negative Breast Cancer.
N Engl J Med 382 (9): 810-821, 2020.[PUBMED Abstract] Schmid P, Cortes J, Dent R, et al.: Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
N Engl J Med 386 (6): 556-567, 2022.[PUBMED Abstract] Yu KD, Ye FG, He M, et al.: Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.
JAMA Oncol 6 (9): 1390-1396, 2020.[PUBMED Abstract] Wang X, Wang SS, Huang H, et al.: Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.